lunes, 26 de diciembre de 2016

Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer - The ASCO Post

Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer - The ASCO Post

Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer

Key Points

  • Plasma circulating tumor DNA (ctDNA) is an independent prognostic marker in patients with advanced pancreatic cancer and is associated with poorer overall survival.
  • Identifying ctDNA in blood samples using next-generation sequencing offers great potential as a noninvasive strategy for patient care and follow-up.
  • ctDNA is a promising blood biomarker, providing information about molecular abnormalities, and is associated with a prognostic and/or predictive value in other malignancies. 

No hay comentarios:

Publicar un comentario